heparin: inhibit blood clot formation

Property	Similarity
inhibit blood clot formation	1.00
prevent blood from clotting	0.87
prevents blood from clotting	0.86
prevent clotting	0.84
inhibit pcr	0.78
prolonged thrombin time	0.76
be used for pulmonary embolism	0.76
induced thrombocytopenia cause thrombosis	0.75
contraindicated in subarachnoid hemorrhage	0.75

0.66

Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.87

Evidence: 0.83

Remarkable(heparin, inhibit blood clot formation) ⋁

Evidence: 0.65

¬ Remarkable(heparin, prevent blood from clotting)

0.64

Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.86

Evidence: 0.83

Remarkable(heparin, inhibit blood clot formation) ⋁

Evidence: 0.75

¬ Remarkable(heparin, prevents blood from clotting)

0.63

Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.84

Evidence: 0.83

Remarkable(heparin, inhibit blood clot formation) ⋁

Evidence: 0.74

¬ Remarkable(heparin, prevent clotting)

0.58

Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.78

Evidence: 0.83

Remarkable(heparin, inhibit blood clot formation) ⋁

Evidence: 0.75

¬ Remarkable(heparin, inhibit pcr)

0.58

Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.76

Evidence: 0.83

Remarkable(heparin, inhibit blood clot formation) ⋁

Evidence: 0.58

¬ Remarkable(heparin, be used for pulmonary embolism)

0.57

Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.86

Evidence: 0.69

Salient(heparin, inhibit blood clot formation) ⋁

Evidence: 0.71

¬ Salient(heparin, prevents blood from clotting)

0.57

Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.76

Evidence: 0.83

Remarkable(heparin, inhibit blood clot formation) ⋁

Evidence: 0.73

¬ Remarkable(heparin, prolonged thrombin time)

0.57

Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.75

Evidence: 0.83

Remarkable(heparin, inhibit blood clot formation) ⋁

Evidence: 0.69

¬ Remarkable(heparin, contraindicated in subarachnoid hemorrhage)

0.56

Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.75

Evidence: 0.83

Remarkable(heparin, inhibit blood clot formation) ⋁

Evidence: 0.71

¬ Remarkable(heparin, induced thrombocytopenia cause thrombosis)

0.56

Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.84

Evidence: 0.69

Salient(heparin, inhibit blood clot formation) ⋁

Evidence: 0.69

¬ Salient(heparin, prevent clotting)

0.56

Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.87

Evidence: 0.69

Salient(heparin, inhibit blood clot formation) ⋁

Evidence: 0.77

¬ Salient(heparin, prevent blood from clotting)

0.55

Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.78

Evidence: 0.69

Salient(heparin, inhibit blood clot formation) ⋁

Evidence: 0.57

¬ Salient(heparin, inhibit pcr)

0.52

Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.86

Evidence: 0.50

Plausible(heparin, inhibit blood clot formation) ⋁

Evidence: 0.57

¬ Plausible(heparin, prevents blood from clotting)

0.52

Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.84

Evidence: 0.50

Plausible(heparin, inhibit blood clot formation) ⋁

Evidence: 0.56

¬ Plausible(heparin, prevent clotting)

0.52

Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.78

Evidence: 0.50

Plausible(heparin, inhibit blood clot formation) ⋁

Evidence: 0.45

¬ Plausible(heparin, inhibit pcr)

0.51

Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.78

Evidence: 0.41

Typical(heparin, inhibit blood clot formation) ⋁

Evidence: 0.39

¬ Typical(heparin, inhibit pcr)

0.50

Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.86

Evidence: 0.41

Typical(heparin, inhibit blood clot formation) ⋁

Evidence: 0.54

¬ Typical(heparin, prevents blood from clotting)

0.49

Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.84

Evidence: 0.41

Typical(heparin, inhibit blood clot formation) ⋁

Evidence: 0.53

¬ Typical(heparin, prevent clotting)

0.49

Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.87

Evidence: 0.50

Plausible(heparin, inhibit blood clot formation) ⋁

Evidence: 0.68

¬ Plausible(heparin, prevent blood from clotting)

0.48

Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.76

Evidence: 0.69

Salient(heparin, inhibit blood clot formation) ⋁

Evidence: 0.80

¬ Salient(heparin, be used for pulmonary embolism)

0.48

Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.76

Evidence: 0.69

Salient(heparin, inhibit blood clot formation) ⋁

Evidence: 0.83

¬ Salient(heparin, prolonged thrombin time)

0.46

Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.75

Evidence: 0.69

Salient(heparin, inhibit blood clot formation) ⋁

Evidence: 0.88

¬ Salient(heparin, contraindicated in subarachnoid hemorrhage)

0.45

Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.75

Evidence: 0.69

Salient(heparin, inhibit blood clot formation) ⋁

Evidence: 0.93

¬ Salient(heparin, induced thrombocytopenia cause thrombosis)

0.43

Rule weight: 0.85
Evidence weight: 0.58
Similarity weight: 0.87

Evidence: 0.41

Typical(heparin, inhibit blood clot formation) ⋁

Evidence: 0.71

¬ Typical(heparin, prevent blood from clotting)

0.41

Rule weight: 0.85
Evidence weight: 0.64
Similarity weight: 0.76

Evidence: 0.50

Plausible(heparin, inhibit blood clot formation) ⋁

Evidence: 0.72

¬ Plausible(heparin, prolonged thrombin time)

0.40

Rule weight: 0.85
Evidence weight: 0.63
Similarity weight: 0.76

Evidence: 0.50

Plausible(heparin, inhibit blood clot formation) ⋁

Evidence: 0.74

¬ Plausible(heparin, be used for pulmonary embolism)

0.39

Rule weight: 0.85
Evidence weight: 0.60
Similarity weight: 0.75

Evidence: 0.50

Plausible(heparin, inhibit blood clot formation) ⋁

Evidence: 0.79

¬ Plausible(heparin, contraindicated in subarachnoid hemorrhage)

0.38

Rule weight: 0.85
Evidence weight: 0.58
Similarity weight: 0.76

Evidence: 0.41

Typical(heparin, inhibit blood clot formation) ⋁

Evidence: 0.71

¬ Typical(heparin, prolonged thrombin time)

0.37

Rule weight: 0.85
Evidence weight: 0.58
Similarity weight: 0.75

Evidence: 0.50

Plausible(heparin, inhibit blood clot formation) ⋁

Evidence: 0.84

¬ Plausible(heparin, induced thrombocytopenia cause thrombosis)

0.34

Rule weight: 0.85
Evidence weight: 0.53
Similarity weight: 0.76

Evidence: 0.41

Typical(heparin, inhibit blood clot formation) ⋁

Evidence: 0.80

¬ Typical(heparin, be used for pulmonary embolism)

0.33

Rule weight: 0.85
Evidence weight: 0.52
Similarity weight: 0.75

Evidence: 0.41

Typical(heparin, inhibit blood clot formation) ⋁

Evidence: 0.81

¬ Typical(heparin, contraindicated in subarachnoid hemorrhage)

0.32

Rule weight: 0.85
Evidence weight: 0.49
Similarity weight: 0.75

Evidence: 0.41

Typical(heparin, inhibit blood clot formation) ⋁

Evidence: 0.86

¬ Typical(heparin, induced thrombocytopenia cause thrombosis)

Parents	drug Weight: 0.72 , blood Weight: 0.57 , agent Weight: 0.56 , molecule Weight: 0.56
Siblings	acetaminophen Weight: 0.37 , fentanyl Weight: 0.37 , warfarin Weight: 0.36 , vancomycin Weight: 0.36

heparin: inhibit blood clot formation

Related concepts

Related properties

Priors about this statement

Cues

Evidence

Clauses

Salient implies Plausible

Similarity expansion

Typical and Remarkable implies Salient

Typical implies Plausible